(Q42497254)

English

A novel multi-targeted tyrosine kinase inhibitor, linifanib (ABT-869), produces functional and structural changes in tumor vasculature in an orthotopic rat glioma model

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 November 2017

A novel multi-targeted tyrosine kinase inhibitor, linifanib (ABT-869), produces functional and structural changes in tumor vasculature in an orthotopic rat glioma model (English)

1 reference

Europe PubMed Central

1 November 2017

author name string

Yanping Luo

1

1 reference

Europe PubMed Central

1 November 2017

Fang Jiang

2

1 reference

Europe PubMed Central

1 November 2017

Todd B Cole

3

1 reference

Europe PubMed Central

1 November 2017

Vincent P Hradil

4

1 reference

Europe PubMed Central

1 November 2017

David Reuter

5

1 reference

Europe PubMed Central

1 November 2017

Arunava Chakravartty

6

1 reference

Europe PubMed Central

1 November 2017

Daniel H Albert

7

1 reference

Europe PubMed Central

1 November 2017

Steven K Davidsen

8

1 reference

Europe PubMed Central

1 November 2017

Bryan F Cox

9

1 reference

Europe PubMed Central

1 November 2017

Evelyn M McKeegan

10

1 reference

Europe PubMed Central

1 November 2017

Gerard B Fox

11

1 reference

Europe PubMed Central

1 November 2017

publication date

12 November 2011

1 reference

Europe PubMed Central

1 November 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

1 November 2017

69

1 reference

Europe PubMed Central

1 November 2017

4

1 reference

Europe PubMed Central

1 November 2017

911-921

1 reference

Europe PubMed Central

1 November 2017

https://scigraph.springernature.com/pub.10.1007/s00280-011-1740-7

0 references

Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Tumorigenesis and the angiogenic switch

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Lectin intravital perfusion studies in tumor-bearing mice: micrometer-resolution, wide-area mapping of microvascular labeling, distinguishing efficiently and inefficiently perfused microregions in the tumor

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Isolation of a tumor factor responsible for angiogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

VEGF blocking therapy in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Angiogenesis in brain tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

A new method of lectin histochemistry for the study of brain angiogenesis. Lectin angiography.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Angiogenesis in malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Genetic characterization of commonly used glioma cell lines in the rat animal model system

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Modeling tracer kinetics in dynamic Gd-DTPA MR imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Vascular morphology and angiogenesis in glial tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1740-7

21 January 2018

Identifiers

10.1007/S00280-011-1740-7

1 reference

Europe PubMed Central

1 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42497254&oldid=1959882234"